181 related articles for article (PubMed ID: 37026608)
1. Biological role of the bidirectional interaction between epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinomas: A systematic review.
Morais HG; Costa CS; Gonçalo RI; Carlan LM; Morais EF; Galvão HC; Freitas RD
Med Oral Patol Oral Cir Bucal; 2023 Jul; 28(4):e395-e403. PubMed ID: 37026608
[TBL] [Abstract][Full Text] [Related]
2. Biological role of epithelial-mesenchymal-transition-inducing transcription factors in head and neck squamous cell carcinoma: A systematic review.
de Morais EF; Rolim LSA; de Melo Fernandes Almeida DR; de Farias Morais HG; de Souza LB; de Almeida Freitas R
Arch Oral Biol; 2020 Nov; 119():104904. PubMed ID: 32947165
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
Ock CY; Kim S; Keam B; Kim M; Kim TM; Kim JH; Jeon YK; Lee JS; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
Oncotarget; 2016 Mar; 7(13):15901-14. PubMed ID: 26893364
[TBL] [Abstract][Full Text] [Related]
4. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
5. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 Influences Cell Spreading, Migration and Invasion in Head and Neck Cancer Cells.
Eichberger J; Schulz D; Pscheidl K; Fiedler M; Reichert TE; Bauer RJ; Ettl T
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138288
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
8. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
[TBL] [Abstract][Full Text] [Related]
9. PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers.
Wu T; Tang C; Tao R; Yong X; Jiang Q; Feng C
Front Immunol; 2021; 12():693881. PubMed ID: 34552581
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue types.
Wang C; Hahn E; Slodkowska E; Eskander A; Enepekides D; Higgins K; Vesprini D; Liu SK; Downes MR; Xu B
Hum Pathol; 2018 Dec; 82():131-139. PubMed ID: 30075156
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1).
Michikawa C; Gopalakrishnan V; Harrandah AM; Karpinets TV; Garg RR; Chu RA; Park YP; Chukkapallia SS; Yadlapalli N; Erikson-Carter KC; Gleber-Netto FO; Sayour E; Progulske-Fox A; Chan EKL; Wu X; Zhang J; Jobin C; Wargo JA; Pickering CR; Myers JN; Silver N
Neoplasia; 2022 Sep; 31():100813. PubMed ID: 35834946
[TBL] [Abstract][Full Text] [Related]
12. TWIST1 regulates proliferation, migration, and invasion and is a prognostic marker for oral tongue squamous cell carcinoma.
de Morais EF; de Farias Morais HG; de Moura Santos E; Barboza CAG; Téo FH; Salo T; Coletta RD; de Almeida Freitas R
J Oral Pathol Med; 2023 Feb; 52(2):127-135. PubMed ID: 36285599
[TBL] [Abstract][Full Text] [Related]
13. Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer: A Systematic Review and Meta-analysis.
Blažek T; Petráš M; Knybel L; Cvek J; Soumarová R
JAMA Netw Open; 2023 Mar; 6(3):e236324. PubMed ID: 37000447
[TBL] [Abstract][Full Text] [Related]
14. [Current events in immunotherapy for upper aerodigestive tract cancer].
Outh-Gauer S; Le Tourneau C; Broudin C; Scotte F; Roussel H; Hans S; Mandavit M; Tartour E; Badoual C
Ann Pathol; 2017 Feb; 37(1):79-89. PubMed ID: 28111039
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review.
Morais EF; Morais HG; Martins HD; Carlan LM; Costa AD; Freitas RD
Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e301-e309. PubMed ID: 35717622
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.
Strati A; Koutsodontis G; Papaxoinis G; Angelidis I; Zavridou M; Economopoulou P; Kotsantis I; Avgeris M; Mazel M; Perisanidis C; Sasaki C; Alix-Panabières C; Lianidou E; Psyrri A
Ann Oncol; 2017 Aug; 28(8):1923-1933. PubMed ID: 28838214
[TBL] [Abstract][Full Text] [Related]
17. Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck.
De Meulenaere A; Vermassen T; Aspeslagh S; Huvenne W; Van Dorpe J; Ferdinande L; Rottey S
Oral Oncol; 2017 Jul; 70():34-42. PubMed ID: 28622889
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
19. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
[TBL] [Abstract][Full Text] [Related]
20. CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.
Lee Y; Shin JH; Longmire M; Wang H; Kohrt HE; Chang HY; Sunwoo JB
Clin Cancer Res; 2016 Jul; 22(14):3571-81. PubMed ID: 26864211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
